Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.01.30.635798

Melanization regulates wound healing by limiting polyploid cell growth in the Drosophila epithelium post injury

Gonzalez-Baez, L.·Mortati, E.·Mitchell, L.·Losick, V.
View original source ↗Export metadata ↓

Abstract

Wound healing requires a localized response that restricts growth, remodeling, and inflammation to the site of injury. In the fruit fly, Drosophila melanogaster, the epithelium heals puncture wounds through cell growth instead of cell division. Epithelial cells on wound margin both fuse and duplicate their genome to generate a multinucleated, polyploid cell essential for tissue repair. Despite the essential role of polyploidy in wound healing, the signals that initiate and regulate the extent of cell growth at the wound site remain poorly understood. One of the first steps in wound healing requires the deposit of melanin at the site of injury, which persists as a melanin scar. The melanin scar forms within hours after a puncture wound and is dependent on the activation of three prophenoloxidase genes (PPO1, PPO2, and PPO3). Using a triple loss of function mutant (PPOnull), we have uncovered a novel role for melanization in regulating wound healing by limiting polyploid cell growth post injury. Thus, melanization is required for efficient wound closure and its loss leads to an unexpected exacerbation of polyploid cell growth in the surrounding epithelial cells. This occurs, in part, through the early entry of epithelial cells into the endocycle, which may be due to altered gene expression as a result of delayed JNK signaling and other pathways. In conclusion, we have found that polyploid cell growth requires melanization at the injury site to control the extent of cell growth and regulate wound repair. SUMMARYPuncture wounds in insects are known to lead to production of a pigmented (melanin) deposit that can persist as a scar, remodeling the site of damage. It has long been speculated that the melanin scar is necessary for tissue repair, thus we used the fruit fly as a model to determine how loss of scar formation affects wound healing. In doing so, we discovered that the melanin scar is necessary to restrict cell growth and facilitate efficient wound closure. Thus, revealing a pivotal role for scar formation in coordinating cell growth, which may be conserved in other organisms.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gonzalez-Baez, L., Mortati, E., Mitchell, L., Losick, V.. 2025-02-04. Melanization regulates wound healing by limiting polyploid cell growth in the Drosophila epithelium post injury. https://doi.org/10.1101/2025.01.30.635798

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗